We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

99 hedge funds and large institutions have $560M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 36 increasing their positions, 33 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more capital invested

Capital invested by funds: $436M → $560M (+$124M)

9% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 33

4% less funds holding

Funds holding: 103 → 99 (-4)

15% less first-time investments, than exits

New positions opened: 22 | Existing positions closed: 26

Holders
99
Holders Change
-4
Holders Change %
-3.88%
% of All Funds
2.87%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.06%
New
22
Increased
36
Reduced
33
Closed
26
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NIMC
NWQ Investment Management Company
California
+$15.3M
2
Franklin Resources
Franklin Resources
California
+$12.9M
3
PCM
Penn Capital Management
Pennsylvania
+$11.5M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
+$11.5M
5
BFA
BlackRock Fund Advisors
California
+$7.79M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$20.7M
2
CS
Credit Suisse
Switzerland
-$13.8M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$9.55M
4
JP Morgan Chase
JP Morgan Chase
New York
-$7.2M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$3.76M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
101
Balyasny Asset Management
Illinois
– -$9.55M -468,109 Closed
Two Sigma Investments
102
Two Sigma Investments
New York
– -$2.62M -128,334 Closed
WC
103
Wexford Capital
Florida
– -$1.96M -95,890 Closed
CII
104
CR Intrinsic Investors
Connecticut
– -$1.91M -93,677 Closed
HCM
105
Highbridge Capital Management
New York
– -$1.55M -76,007 Closed
PP
106
PDT Partners
New York
– -$1.27M -62,049 Closed
KIA
107
Kopp Investment Advisors
Minnesota
– -$815K -39,934 Closed
SIM
108
Spark Investment Management
New York
– -$771K -37,800 Closed
Nomura Holdings
109
Nomura Holdings
Japan
– -$734K -35,956 Closed
KCM
110
Kingdon Capital Management
New York
– -$510K -25,000 Closed
DC
111
Deere & Company
Illinois
– -$504K -24,705 Closed
SCA
112
SAC Capital Advisors
Connecticut
– -$492K -24,130 Closed
Citadel Advisors
113
Citadel Advisors
Florida
– -$443K -21,697 Closed
EMG
114
Ellington Management Group
Connecticut
– -$418K -20,500 Closed
AQR Capital Management
115
AQR Capital Management
Connecticut
– -$403K -19,766 Closed
CBOA
116
Commonwealth Bank of Australia
Australia
– -$330K -16,189 Closed
HHC
117
Hutchin Hill Capital
New York
– -$259K -12,700 Closed
SCM
118
Stevens Capital Management
Pennsylvania
– -$204K -9,997 Closed
BJ
119
BlackRock Japan
Japan
– -$126K -6,175 Closed
CAM
120
ClariVest Asset Management
California
– -$57K -2,800 Closed
U
121
UBS
Switzerland
– -$45K -2,212 Closed
Wells Fargo
122
Wells Fargo
California
– -$41K -1,986 Closed
PCM
123
Prelude Capital Management
New York
– -$32K -1,550 Closed
MCM
124
Mazama Capital Management
Oregon
– -$28K -1,381 Closed
Ameriprise
125
Ameriprise
Minnesota
– -$21K -1,040 Closed
1 2 3 4
5

SGNT Hedge Fund Activity: Q4 2013 in Review

99 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2013, worth a combined $560M — up 28% from $436M a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of SGNT and 22 opened new positions — a net loss of 4 holders — while 33 trimmed existing stakes and 36 added.

The largest buyer was NWQ Investment Management Company, opening a new position worth an estimated $15.3M. The largest seller was Deerfield Management, exiting entirely with an estimated $20.7M sold.

  • 99 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2013, down from 103 in Q3 2013.
  • Funds reported $560M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2013, up 28% quarter-over-quarter.
  • 22 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2013 and 26 closed out, a net change of -4 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2013 was NWQ Investment Management Company, an estimated $15.3M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2013 was Deerfield Management, an estimated $20.7M sold.

Based on aggregated 13F filings for Q4 2013.